Clinical Trial

Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).

Name: Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD). — clinical trial record (NCT07476872)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CONTINUUM-GVHD

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the safety and efficacy of Gecacitinib in patients with steroid-refractory/dependent active chronic graft versus host disease (cGVHD).

Trial Details

NCT Number	NCT07476872
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	cGVHD, HSCT
Enrollment	33 participants
Start Date	2026-03-16
Primary Completion	2027-11-01 (estimated)
Study Completion	2028-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-17